$10.64
+0.35 (+3.40%)
Open$10.38
Previous Close$10.29
Day High$10.67
Day Low$10.38
52W High$14.51
52W Low$5.90
Volume—
Avg Volume850.2K
Market Cap714.44M
P/E Ratio—
EPS$-1.22
SectorPharmaceuticals
Analyst Ratings
Buy
26 analysts
Price Target
+522.4% upside
Current
$10.64
$10.64
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 239.91M | 190.46M | 233.97M |
| Net Income | -73,815,119 | -52,741,828 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -105,884,148 | -79,858,638 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |